Indicateurs
1 Consultations de la notice
- Titre
- CO78 Dupilumab Improves Lung Function and Asthma Control While Reducing Systemic Corticosteroid Use in Patients With Allergic Bronchopulmonary Aspergillosis: The Phase 2 LIBERTY ABPA AIRED Study
- Créateurs - sans rôle
- Arnaud Bourdin - PhyMedExp, University of Montpellier, Montpellier, FranceJonathan Corren - David Geffen School of Medicine at UCLAAnand Shah - Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United KingdomCaroline G. Baxter - Manchester University NHS Foundation Trust, Manchester, United KingdomLavina Davidescu - University of Oradea, Oradea, RomaniaHeather Paleczny - Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAJoseph Chiarappa - Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAAndrew Fontenot - Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAPaula Dakin - Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAElizabeth Laws - Sanofi, Cambridge, MA, USAJennifer Maloney - Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USALacey B. Robinson - Sanofi, Cambridge, MA, USAAllen Radin - Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
- Détails de publication
- Value in health, Vol.28(12), pp.S57-S57
- Éditeur
- Elsevier Inc
- Identifiants
- 99158890209311
- Unité académique
- Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
- Langue
- English
- Type de ressource
- Journal article